News & Alerts
-
Nov- 2023 -21 November
Bayer Shares Plunge After Stoppage of Key Drug Trial
Bayer, the German multinational pharmaceutical company, experienced a severe setback as its shares plummeted to the lowest level in over…
Read More » -
21 November
Polaris Market Research Unveils Extensive Report on the “Green Food Supplements Market” Offering In-Depth Insights
Polaris Market Research has released a detailed research report spanning over 110 pages, providing a comprehensive view of the “Green…
Read More » -
21 November
Ewing’s Sarcoma Treatment Market Analysis – Technavio
The Ewing’s sarcoma treatment market is set to witness significant growth, with Technavio Research forecasting a USD 205.09 million expansion…
Read More » -
21 November
Key Market Analysis of Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan Anemia in the Inherited Types of Anemia Therapeutic Space
Overview: Anemia, a significant public health challenge, affects various demographic groups, including young children, pregnant and postpartum women, and menstruating…
Read More » -
20 November
Porton Advanced Partners with Ascle Therapeutics for Innovative NK Cell Therapy Development
In a groundbreaking development, Porton Advanced has recently unveiled a strategic collaboration with Ascle Therapeutics, aimed at advancing the joint…
Read More » -
20 November
Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges
Roche Molecular Systems, Inc. has introduced the LightCycler® PRO System, marking a significant advancement in quantitative Polymerase Chain Reaction (qPCR)…
Read More » -
20 November
Alarming Surge in Drug Shortages Revealed in Latest IQVIA Report
In the unfolding crisis of drug shortages, the latest report from IQVIA Institute has revealed alarming statistics, indicating that the…
Read More » -
18 November
Compounding Pharmacy Market Size Forecasted to Increase By $1,682.04 Million Between 2023-2027
The compounding pharmacy market is anticipated to experience a Compound Annual Growth Rate (CAGR) of 2.18% from 2022 to 2027,…
Read More » -
18 November
First Asthma-Linked Death in Cannabis Industry Highlights Respiratory Hazards
In a tragic turn of events, a 27-year-old woman employed at a Massachusetts cannabis-processing facility became the first reported fatality…
Read More » -
18 November
FDA Approves Truqap (capivasertib) plus Faslodex for Patients with Advanced HR-Positive Breast Cancer
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients…
Read More »